FDA Lot-Release Authorizations
These memos show the authority for the manufacturer to release anthrax vaccine from
the manufacturing plant. Each lot of every vaccine produced in the United States
must be individually released in this way, after having been tested for sterility,
purity, potency, and general safety. Lot-release tests are performed by the manufacturer
and audited by FDA.
View Pre-Renovation Lots